246 related articles for article (PubMed ID: 16875158)
1. [Effect of aprotinin on selected parameters of coagulation and drainage blood loss after cardiac operations in patients without coagulation disorders].
Hirnle T; Stachurski A; Goździk W; Pelczar M; Wachnik J; Hirnle G; Milczarska J; Kustrzycki W
Pol Merkur Lekarski; 2006 May; 20(119):543-6. PubMed ID: 16875158
[TBL] [Abstract][Full Text] [Related]
2. Comparison of three dose regimens of aprotinin in infants undergoing the arterial switch operation.
Verma YS; Chauhan S; Bisoi AK; Gharde P; Kiran U; Das SN
Ann Card Anaesth; 2010; 13(2):110-5. PubMed ID: 20442540
[TBL] [Abstract][Full Text] [Related]
3. Low doses of aprotinin in aortocoronary bypass surgery--advantages and disadvantages.
Golański R; Golański J; Chizyński K; Iwaszkiewicz A; Zasłonka J; Pietrucha T; Chrul S; Watała C
Med Sci Monit; 2000; 6(4):722-8. PubMed ID: 11208399
[TBL] [Abstract][Full Text] [Related]
4. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
Dietrich W; Spannagl M; Boehm J; Hauner K; Braun S; Schuster T; Busley R
Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201
[TBL] [Abstract][Full Text] [Related]
5. Aprotinin in orthotopic liver transplantation: evidence for a prohemostatic, but not a prothrombotic, effect.
Molenaar IQ; Legnani C; Groenland TH; Palareti G; Begliomini B; Terpstra OT; Porte RJ
Liver Transpl; 2001 Oct; 7(10):896-903. PubMed ID: 11679989
[TBL] [Abstract][Full Text] [Related]
6. Hemostatic activation during cardiopulmonary bypass with different aprotinin dosages in pediatric patients having cardiac operations.
Dietrich W; Mössinger H; Spannagl M; Jochum M; Wendt P; Barankay A; Meisner H; Richter JA
J Thorac Cardiovasc Surg; 1993 Apr; 105(4):712-20. PubMed ID: 7682267
[TBL] [Abstract][Full Text] [Related]
7. High dose aprotinin to reduce blood loss in patients undergoing redo open heart surgery.
Biagini A; Comite C; Russo V; Salerno ML; Gemignani R; Pardelli S; Baccellini M; Baroni M; Pugliese S; Maffei S
Acta Anaesthesiol Belg; 1992; 43(3):181-6. PubMed ID: 1280394
[TBL] [Abstract][Full Text] [Related]
8. The impact of aprotinin on blood loss and blood transfusion in off-pump coronary artery bypass grafting.
Bittner HB; Lemke J; Lange M; Rastan A; Mohr FW
Ann Thorac Surg; 2008 May; 85(5):1662-8. PubMed ID: 18442562
[TBL] [Abstract][Full Text] [Related]
9. [Antifibrinolytic agents and repeat open-heart surgery: a comparison of tranexamic acid and low dose aprotinin].
Ait Houssa M; Selkane C; Amahzoune B; El Bekkali Y; Wahid FA; Moutaki Allah Y; Boulahya A; Ibat D; Drissi M; Azendour H; Elkirat A
Ann Cardiol Angeiol (Paris); 2007 Dec; 56(6):308-12. PubMed ID: 17976511
[TBL] [Abstract][Full Text] [Related]
10. [Effect of low dose aprotinin on reduction of blood loss after extracorpreal circulation].
Takahashi K; Hoshino S; Iwaya F; Igari T; Satokawa H; Ono T; Takase S; Ogawa T; Satoh K; Satoh K; Misawa Y; Ishikawa K
Kyobu Geka; 2000 Dec; 53(13):1085-90. PubMed ID: 11127552
[TBL] [Abstract][Full Text] [Related]
11. Low-dose and high-dose aprotinin improve hemostasis in coronary operations.
Speekenbrink RG; Wildevuur CR; Sturk A; Eijsman L
J Thorac Cardiovasc Surg; 1996 Aug; 112(2):523-30. PubMed ID: 8751522
[TBL] [Abstract][Full Text] [Related]
12. Perioperative renal outcome in cardiac surgical patients with preoperative renal dysfunction: aprotinin versus epsilon aminocaproic acid.
Maslow AD; Chaudrey A; Bert A; Schwartz C; Singh A
J Cardiothorac Vasc Anesth; 2008 Feb; 22(1):6-15. PubMed ID: 18249324
[TBL] [Abstract][Full Text] [Related]
13. [Effect of aprotinin on bleeding during and graft patency after coronary artery bypass grafting].
Minohara S; Asada K; Kondo K; Tatsumi T; Hasegawa S; Sawada Y; Morimoto T; Matsuyama N; Sasaki S
Nihon Kyobu Geka Gakkai Zasshi; 1997 Jun; 45(6):821-4. PubMed ID: 9217377
[TBL] [Abstract][Full Text] [Related]
14. High-dose aprotinin modulates the balance between proinflammatory and anti-inflammatory responses during coronary artery bypass graft surgery.
Tassani P; Augustin N; Barankay A; Braun SL; Zaccaria F; Richter JA
J Cardiothorac Vasc Anesth; 2000 Dec; 14(6):682-6. PubMed ID: 11139109
[TBL] [Abstract][Full Text] [Related]
15. Effects of minimal dose aprotinin on blood loss and fibrinolytic system-complement activation in coronary artery bypass grafting surgery.
Cicekcioglu F; Cagli K; Emir M; Topbas M; Catav Z; Sener E; Tasdemir O
J Card Surg; 2006; 21(4):336-41. PubMed ID: 16846409
[TBL] [Abstract][Full Text] [Related]
16. Aprotinin in primary cardiac surgery: operative outcome of propensity score-matched study.
Ngaage DL; Cale AR; Cowen ME; Griffin S; Guvendik L
Ann Thorac Surg; 2008 Oct; 86(4):1195-202. PubMed ID: 18805159
[TBL] [Abstract][Full Text] [Related]
17. Aprotinin has no effect on platelet activation and adhesion during cardiopulmonary bypass.
Wahba A; Black G; Koksch M; Rothe G; Preuner J; Schmitz G; Birnbaum DE
Thromb Haemost; 1996 May; 75(5):844-8. PubMed ID: 8725734
[TBL] [Abstract][Full Text] [Related]
18. Activation of hemostasis during cardiopulmonary bypass and pediatric aprotinin dosage.
Mössinger H; Dietrich W
Ann Thorac Surg; 1998 Jun; 65(6 Suppl):S45-50; discussion S50-1, S74-6. PubMed ID: 9647138
[TBL] [Abstract][Full Text] [Related]
19. High-dose aprotinin in cardiac surgery: is high-dose high enough? An analysis of 8281 cardiac surgical patients treated with aprotinin.
Dietrich W; Busley R; Kriner M
Anesth Analg; 2006 Nov; 103(5):1074-81. PubMed ID: 17056935
[TBL] [Abstract][Full Text] [Related]
20. Effect of intraoperative aprotinin administration on postoperative bleeding in patients undergoing cardiopulmonary bypass operation.
Havel M; Teufelsbauer H; Knöbl P; Dalmatiner R; Jaksch P; Zwölfer W; Müller M; Vukovich T
J Thorac Cardiovasc Surg; 1991 Jun; 101(6):968-72. PubMed ID: 1710009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]